RPP SRL

Lobbying Organisation RPP SRL

Date published 14 May, 2026

Relevant Matter Legislation

Public Policy Area Health

Period 1 Jan. 2026 to 30 Apr. 2026

Specific Details The primary objective of the project is to organise an event at the European Parliament to raise awareness of hypoparathyroidism and its significant unmet medical needs.

Intended results Improve recognition, care, and policy support for people living with hypoparathyroidismthis, a rare endocrine condition across the EU

Name of person primarily responsible for lobbying on this activity King Wojtowicz

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? Yes

Client(s)

Client 1

Company name Ascendis Pharma

CRO number (if applicable)

Company address Tuborg Boulevard 12 2900 Hellerup Denmark

Main business or activity

Company website https://ascendispharma.com/

Contact email address mihe@ascendispharma.com

Contact phone number

Contact address same as Principal

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (1)

Letter (1)

Billy Kelleher MEP did not engage with this project

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Billy Kelleher MEP (European Parliament)